Ashland Inc (ASH)
97.23
+0.55
(+0.57%)
USD |
NYSE |
Mar 21, 16:00
97.17
-0.06
(-0.06%)
Pre-Market: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.277B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 4.28% |
| Valuation | |
| PE Ratio | 6.035 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.224 |
| Price to Book Value | 1.590 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.335 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3966 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 52.83% |
News
Headline
Wire
Time (ET)
Yahoo
03/16 11:29
Globe Newswire
03/08 07:00
Yahoo
02/17 11:16
MT Newswires
02/02 11:35
MT Newswires
02/02 10:59
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 04/27/2023* | 09:00 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 04/26/2023* | -- | Results | Q2 2023 | -- | 1.47 | -- | |
| 02/01/2023 | -- | Results | Q1 2023 | 0.97 | 0.94 | 2.68% | |
| 02/01/2023 | 09:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 11/08/2022 | 09:00 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 11/07/2022 | -- | Results | Q4 2022 | 1.46 | 1.41 | 3.37% | |
| 07/27/2022 | 09:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/26/2022 | -- | Results | Q3 2022 | 1.89 | 1.74 | 8.82% |
*Estimated Date/Time
Earnings
Profile
Edit
| Ashland Inc is a global specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into five distinct segments: life sciences, personal care and household, performance adhesives, specialty additives, and intermediates and solvents. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. There is not a single segment that represents a majority of revenue given its extensive portfolio of products. A large portion of revenue is generated outside of the United States and there is higher demand for the company’s services during warmer weather months. |
| URL | http://www.ashland.com |
| Investor Relations URL | https://investor.ashland.com/ |
| HQ State/Province | Delaware |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 26, 2023 (est.) |
| Last Earnings Release | Feb. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 28, 2023 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 1.305 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.9829 |
| Yield to Sector | 0.3664 |
| Yield to Industry | 0.4589 |
| Last Dividend Amt. | 0.335 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Feb. 28, 2023 |
| Yield (TTM) | 1.38% |
| Forward Yield | 1.38% |
| Payout Ratio | 7.73% |
| Cash Payout Ratio | -17.62% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 21, 2023.
Fundamentals
| Revenue (TTM) | 2.405B |
| Total Expenses (TTM) | 2.123B |
| Net Income (TTM) | 919.00M |
| Total Assets (Quarterly) | 6.259B |
| Total Liabilities (Quarterly) | 2.941B |
| Shareholders Equity (Quarterly) | 3.318B |
| Cash from Operations (TTM) | -282.00M |
| Cash from Investing (TTM) | 1.537B |
| Cash from Financing (TTM) | -912.00M |
Ratings
Profile
Edit
| Ashland Inc is a global specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into five distinct segments: life sciences, personal care and household, performance adhesives, specialty additives, and intermediates and solvents. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. There is not a single segment that represents a majority of revenue given its extensive portfolio of products. A large portion of revenue is generated outside of the United States and there is higher demand for the company’s services during warmer weather months. |
| URL | http://www.ashland.com |
| Investor Relations URL | https://investor.ashland.com/ |
| HQ State/Province | Delaware |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Blend |
| Next Earnings Release | Apr. 26, 2023 (est.) |
| Last Earnings Release | Feb. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 28, 2023 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ASH Tweets |